James B. Renacci sold GlaxoSmithKline PLC ADR (NYSE: GSK)
James B. Renacci (R-OH), a U.S. Representative, has disclosed 2 trades in GlaxoSmithKline PLC ADR (GSK) since 2014, all sales, worth an estimated $83K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: James B. Renacci sold $50,001 - $100,000 of GlaxoSmithKline PLC ADR (NYSE: GSK) on January 10, 2014. Since that trade, GSK is up +87.05% against the S&P 500 up +387.71%, an outperformance of -300.66%.
Across these filings, James B. Renacci has been a net seller of GSK. The most recent disclosed GSK transaction shown was dated October 24, 2014. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
James B. Renacci's GSK trades vs the price
GSK is up +87.05% since James B. Renacci sold on January 10, 2014, versus +387.71% for the S&P 500.
Performance since this trade
All James B. Renacci GSK trades
James B. Renacci & GSK trading FAQ
Is it legal for James B. Renacci to trade GlaxoSmithKline PLC ADR (GSK) stock?
Yes. Members of Congress are allowed to trade individual stocks, including GlaxoSmithKline PLC ADR (GSK), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did James B. Renacci sell GSK?
James B. Renacci disclosed a sale of $50,001 - $100,000 of GlaxoSmithKline PLC ADR (GSK) on January 10, 2014, according to public STOCK Act filings.
How has GSK performed since James B. Renacci's trade?
Since James B. Renacci sold GSK on January 10, 2014, the stock is up +87.05%, versus +387.71% for the S&P 500 over the same period, an outperformance of -300.66%.
How many times has James B. Renacci traded GSK?
James B. Renacci has disclosed 2 GSK trades since 2014. Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional GSK trades?
Quantellect tracks every disclosed congressional trade in GlaxoSmithKline PLC ADR (GSK) on the GlaxoSmithKline PLC ADR congressional trading page, which aggregates filings across all members of Congress.
James B. Renacci's GSK tradesAll congressional filings for GlaxoSmithKline PLC ADRJames B. Renacci's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.